GLP-1 Receptor Agonist Trial: Semaglutide Reduces Alcohol Cravings
Comments Off on GLP-1 Receptor Agonist Trial: Semaglutide Reduces Alcohol Cravings
May 5, 2026
The semaglutide alcohol cravings trial highlights the potential of GLP-1 receptor agonists in reducing alcohol consumption and craving intensity. This study demonstrates semaglutide's role in modulating reward pathways linked to addiction. Semaglutide…
Clinical Evidence of Semaglutide in Alcohol Use Disorder
Comments Off on Clinical Evidence of Semaglutide in Alcohol Use Disorder
May 5, 2026
Semaglutide alcohol use disorder clinical evidence reveals promising reductions in alcohol consumption among severe AUD patients. This expands GLP-1 receptor agonists' role beyond metabolic effects. Understanding this evidence helps clinicians consider…